Apeiron Investment Group Ltd., 10% Owner, Director at ATAI Life Sciences N.V. (ATAI), bought 21,671,436 shares at $2.10 ($45.5M) on 2025-02-14, disclosed to the SEC on 2025-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.10 | 10,835,718 | $22.8M | 50.0% |
| 2 | $2.10 | 10,835,718 | $22.8M | 50.0% |
| Total | $2.10 avg | 21,671,436 | $45.5M | 100% |
| Filing → |
| ENHA | BUY | 2026-09-04 | $210K | — | Filing → |
| ENHA | BUY | 2026-08-20 | $2.9M | — | Filing → |
| ENHA | BUY | 2026-08-18 | $330K | — | Filing → |